Van Bortel L - Search Results

1

Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions.

Kruse V, Somers A, Van Bortel L, De Both A, Van Belle S, Rottey S. Kruse V, et al. Among authors: van belle s, van bortel l. J Clin Pharm Ther. 2014 Jun;39(3):259-65. doi: 10.1111/jcpt.12134. Epub 2014 Jan 13. J Clin Pharm Ther. 2014. PMID: 24417304

2

Cardiac toxicity of trastuzumab: experience at the Ghent Unversity Hospital, Belgium.

Lamot C, Rottey S, De Backer T, Van Bortel L, Robays H, Van Belle S, Denys H, Cocquyt V. Lamot C, et al. Among authors: van belle s, van bortel l. Acta Clin Belg. 2010 Sep-Oct;65(5):300-4. doi: 10.1179/acb.2010.066. Acta Clin Belg. 2010. PMID: 21128555

3

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M. Mehuys E, et al. Among authors: van tongelen i, van bortel l. J Clin Pharm Ther. 2011 Oct;36(5):602-13. doi: 10.1111/j.1365-2710.2010.01218.x. Epub 2010 Dec 8. J Clin Pharm Ther. 2011. PMID: 21143256 Clinical Trial.

4

Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions.

Khalilieh SG, Yee KL, Sanchez RI, Fan L, Anderson MS, Sura M, Laethem T, Rasmussen S, van Bortel L, van Lancker G, Iwamoto M. Khalilieh SG, et al. Among authors: van bortel l. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02016-18. doi: 10.1128/AAC.02016-18. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30783000 Free PMC article.

5

Investigation of combined CYP3A4 inductive/inhibitory properties by studying statin interactions: a model study with the renin inhibitor ACT-178882.

Dingemanse J, Nicolas LB, van Bortel L. Dingemanse J, et al. Among authors: van bortel l. Eur J Clin Pharmacol. 2014 Jun;70(6):675-84. doi: 10.1007/s00228-014-1674-1. Epub 2014 Apr 15. Eur J Clin Pharmacol. 2014. PMID: 24728182 Clinical Trial.

6

Switchability of Gabapentin Formulations: A Randomized Trial to Assess Bioequivalence Between Neurontin and Gabasandoz on the Individual Subject Level.

Van Lancker G, Van Bortel L, Delafontaine B, Boussery K, Swart E, Chahbouni A, Van Bocxlaer J, Colin P. Van Lancker G, et al. Among authors: van bortel l. Clin Pharmacol Ther. 2019 Jul;106(1):195-203. doi: 10.1002/cpt.1353. Epub 2019 Mar 2. Clin Pharmacol Ther. 2019. PMID: 30636281 Clinical Trial.

7

COPD management in primary care: an observational, community pharmacy-based study.

Mehuys E, Boussery K, Adriaens E, Van Bortel L, De Bolle L, Van Tongelen I, Remon JP, Brusselle G. Mehuys E, et al. Among authors: van tongelen i, van bortel l. Ann Pharmacother. 2010 Feb;44(2):257-66. doi: 10.1345/aph.1M481. Epub 2010 Jan 26. Ann Pharmacother. 2010. PMID: 20103611

8

AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety.

Struys MM, Vanluchene AL, Gibiansky E, Gibiansky L, Vornov J, Mortier EP, Van Bortel L. Struys MM, et al. Among authors: van bortel l. Anesthesiology. 2005 Oct;103(4):730-43. doi: 10.1097/00000542-200510000-00011. Anesthesiology. 2005. Retraction in: Anesthesiology. 2010 Apr;112(4):1056-7. doi: 10.1097/ALN.0b013e3181d536df Retraction in: Anesthesiology. 2010 Apr;112(4):1058. PMID: 16192765 Retracted. Clinical Trial.

9

A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application.

Verbeke F, Lindley E, Van Bortel L, Vanholder R, London G, Cochat P, Wiecek A, Fouque D, Van Biesen W. Verbeke F, et al. Among authors: van biesen w, van bortel l. Nephrol Dial Transplant. 2014 Mar;29(3):490-6. doi: 10.1093/ndt/gft321. Epub 2013 Sep 26. Nephrol Dial Transplant. 2014. PMID: 24071661

10

Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.

Bourgeois J, Elseviers MM, Van Bortel L, Petrovic M, Vander Stichele RH. Bourgeois J, et al. Among authors: van bortel l. Eur J Clin Pharmacol. 2014 Oct;70(10):1251-60. doi: 10.1007/s00228-014-1725-7. Epub 2014 Aug 8. Eur J Clin Pharmacol. 2014. PMID: 25098683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters